Respiratory News and Research

RSS

Obese asthmatic children more likely to have respiratory complications during or after surgery

A study presented at ANESTHESIOLOGY 2011 found that obese asthmatic children were nearly two times as likely to have at least one respiratory complication during or after surgery compared to their lean peers.

18 Oct 2011

UEA scientists to assess future impact of global warming on allergic diseases

A new study by an international team of scientists including the University of East Anglia (UEA) will assess the future impact of global warming on allergic diseases.

18 Oct 2011

National award encourages bio-science student researchers

A key challenge for the bio-sciences sector is to keep its best research graduates in science and in Australia. The national student awards recognise and encourage promising research students and raise awareness of biosciences research translation and applications.

17 Oct 2011

Indoor cooking stoves kill 2 million annually, NIH study says

Pollution from indoor cooking stoves, typically open fires that that burn solid fuels such as wood, charcoal or dung, kills two million globally each year, scientists at NIH said in a study published in the journal Science on Thursday, Agence France-Presse reports.

15 Oct 2011

Overweight children more likely to develop asthma

Asthma is considered one of the main causes of school absenteeism and its prevalence has risen in the last decades. Overweight children have been shown to have double the frequency of asthma than that of non-obese children.

15 Oct 2011

ABI provides clinical update on company activities

Amarillo Biosciences, Inc. (ABI) today provided an update on company activities.

15 Oct 2011

Teva acquires Cephalon

Teva Pharmaceutical Industries Ltd. announced today that it has completed its acquisition of Cephalon, Inc. The combined company will have a significant presence in over 60 countries and generated approximately $20 billion in revenues on a pro-forma basis for the twelve months ended June 2011.

15 Oct 2011

Million Hearts initiative strikes at leading killer of Americans

The number of Americans who report they have coronary heart disease – which includes heart attack and angina (chest pain) – continues to decline but rates vary widely from state to state and by race and ethnicity, according to a new report published today in the Morbidity and Mortality Weekly Report of the Centers for Disease Control and Prevention.

14 Oct 2011

Four companies receive NIAID contracts to develop broad-spectrum therapeutics

Four companies are to develop broad-spectrum therapeutics-antibiotics, antivirals and an antitoxin-to prevent or treat diseases caused by multiple types of bacteria or viruses, under contracts awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

14 Oct 2011

New insight into how emphysema and COPD develop

By studying mice exposed to tobacco smoke for a period of months, researchers have new insight into how emphysema and chronic obstructive pulmonary disease (COPD) develop.

14 Oct 2011

Researchers control itch without dulling morphine's pain-killing effects

Itching is one of the most prevalent side effects of powerful, pain-killing drugs like morphine, oxycodone and other opioids. The opiate-associated itch is so common that even women who get epidurals for labor pain often complain of itching. For many years, scientists have scratched their own heads about why drugs that so effectively suppress pain also induce itch.

14 Oct 2011

Three key steps to prevent asthma attacks in children during winter

For most people, the word "autumn" conjures up images of honey crisp apples, pumpkin patches and Halloween. But for many pediatricians, fall also means more patients with asthma flare-ups.

13 Oct 2011

Study: Emerging pharmaceutical platform may produce undesirable effects on eye function

According to new research by University of Kentucky investigators, an emerging pharmaceutical platform used in treating a variety of diseases may produce unintended and undesirable effects on eye function.

12 Oct 2011

Furiex announces publications and presentations about antibacterial drug JNJ-Q2

Furiex Pharmaceuticals, Inc. today announced recent and upcoming publications and presentations about the novel investigational antibacterial drug JNJ-Q2.

12 Oct 2011

Secondhand tobacco smoke harms children in China

The more Chinese children are exposed to secondhand tobacco smoke, the more they have symptoms like coughing at night, sneezing, phlegm without a cold, sneezing with itchy-watery eyes and impaired lung-function growth.

11 Oct 2011

Aspirin desensitization procedure can benefit patients with sinusitis, asthma and AERD

Beth Moore can now keep up with her children. The suburban Philadelphia mother of two had suffered from allergies and chronic sinusitis since her teens. With age her symptoms became more severe, turning into bronchitis and eventually asthma, diminishing her ability to breathe and sapping her of her energy. The only complete relief came from aspirin; and the aspirin desensitization that allowed her to overcome her aspirin allergy and end her decades-long battle with sinusitis.

11 Oct 2011

Awards showcase Australia’s promising future in bio-sciences

The six state winners of the AusBiotech/GSK Student Excellence Awards, announced today, will next week compete for the national biosciences research award at AusBiotech 2011.

10 Oct 2011

Boehringer Ingelheim receives FDA approval for COMBIVENT RESPIMAT to treat COPD

Boehringer Ingelheim Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved COMBIVENT RESPIMAT, a new, propellant-free inhaler product that uses a slow-moving mist to deliver the same active ingredients of COMBIVENT Inhalation Aerosol in a metered dose inhaler.

10 Oct 2011

First combination drug to treat type 2 diabetes and high cholesterol receives FDA approval

The U.S. Food and Drug Administration today approved Juvisync (sitagliptin and simvastatin), a fixed-dose combination (FDC) prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin and simvastatin.

7 Oct 2011

Roundup: Brewer defends request for exchange funds; Calif. governor signs maternity benefit bill

Republican Gov. Jan Brewer of Arizona said Thursday that despite opposition from legislators from within her own party, she's seeking money from the federal government to implement a key part of the health care overhaul she opposes in order to prepare her state in case the law is upheld.

7 Oct 2011